ArticleWorld journal of microbiology & biotechnology2020
Biosynthesis of 2,4-diacetylphloroglucinol from glucose using engineered Escherichia coli.
Article in World journal of microbiology & biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- Identification of 2,4-diacetylphloroglucinol production in the genus Chromobacterium.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
In order to produce 2,4-diacetylphloroglucinol (2,4-DAPG) in E. coli, the key synthases coding by phlACBD gene cluster from the strain Pseudomonas fluorescens CHA0 were overexpressed in E. coli BL21 (DE3). The marA, phlE and acc genes were also overexpressed to enhance 2,4-DAPG biosynthesis. Then the fermentation conditions were optimized to improve the concentration of 2,4-DAPG. The results showed that the recombinant E. coli could produce few 2,4-DAPG with only the phlACBD gene cluster. The synthetic ability of 2,4-DAPG could be increased by expressing the acc, marA and phlE genes in shake-flasks cultivation. The effects of phloroglucinol, initial pH, temperature and trace elements on 2,4-DAPG biosynthesis were also investigated. Based on the optimal fermentation conditions obtained from the shake-flasks cultivation, fed-batch fermentation of strain Z3 in a 5 L bioreactor was conducted to produce 2,4-DAPG. Finally, the concentration of 2,4-DAPG was 179 mg/L after induction for 36 h by fed-batch fermentation. To the best of our knowledge, this is the highest 2,4-DAPG production reported in E. coli. This work showed the potential application of engineered E. coli to get high production of target compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.